The Center for Planning and Organization of Drug Provision for Citizens announced an auction with an initial contract price of 91.3 million rubles for the purchase of lanadelumab, a drug for the prevention of angioedema, Farmvestnik reports. The deadline for applications is on January 26, next week.
The Board of Trustees of the Circle of Kindness Foundation made a decision to purchase lanadelumab on October 14, 2021. The auction for its supply was announced for the first time.
In Russia, according to the State Register of Medicines (GRLS), this drug is registered under trade name “Takzairo”. The registration certificate is held by Shire Pharmaceuticals Ireland Limited.
Alexander Tkachenko, Chairman of the Board of the Circle of Kindness Foundation, described the system of providing medicines to children with orphan diseases.